The number of adverse events reported for women is more than three times that reported for men. While it is possible that the large number of female adverse events may be due to sampling bias and not related to gender-specific effects, the disparity in the number of events women suffer is evident. This large discrepancy is a signal that females are likely at greater risk of an adverse event than males, and the signal should be investigated further.
Deliberate?
Latest Pfizer data dump - Oct 10, 2023